title: Predictive factors for an increased risk of sperm aneuploidies in oligo-astheno-teratozoospermic males.
abstract: Patients with severe spermatogenesis impairment can now successfully father a child thanks to the use of intracytoplasmic sperm injection (ICSI). In oligozoospermic patients, many studies have reported significantly higher sperm aneuploidy rates and therefore an increased risk of transmitting a chromosomal abnormality via the injection of abnormal spermatozoa. However, the frequency of aneuploidy is highly variable between patients. The aim of the present work was to identify clinical and biological factors, which, together with non-obstructive oligozoospermia, could be predictive of elevated sperm aneuploidies. The sperm aneuploidy rates for chromosomes X, Y, 13, 18 and 21 were assessed in 31 infertile men with well-characterized spermatogenesis impairment, and in a population of control men with proven fertility. The frequency of sperm aneuploidy was compared between several patient subgroups according to their clinical and biological factors. Nearly half of the oligozoospermic males (15/31) had a significantly increased disomy rate for at least one of the five chromosomes compared with that observed in the control population (mean disomy rates + 1.96 standard deviation). Factors significantly associated with higher numbers of aneuploid sperm were cigarette smoking, an elevated follicle-stimulating hormone level, a sperm concentration less than 1 m/mL, and a severe teratozoospermia. Hence, several factors predictive of an increased risk of sperm aneuploidy rates were identified in ICSI male candidates with a non-obstructive oligozoospermia.
authors.affiliation: INSERM, U309, Grenoble, France.
authors.forename: A K
authors.initials: AK
authors.lastname: Faure
authors.forename: I
authors.initials: I
authors.lastname: Aknin-Seifer
authors.forename: G
authors.initials: G
authors.lastname: Frérot
authors.forename: R
authors.initials: R
authors.lastname: Pelletier
authors.forename: C
authors.initials: C
authors.lastname: De Robertis
authors.forename: C
authors.initials: C
authors.lastname: Cans
authors.forename: R
authors.initials: R
authors.lastname: Levy
authors.forename: C
authors.initials: C
authors.lastname: Jimenez
authors.forename: H
authors.initials: H
authors.lastname: Lejeune
authors.forename: N
authors.initials: N
authors.lastname: Terrier
authors.forename: U
authors.initials: U
authors.lastname: Bergues
authors.forename: S
authors.initials: S
authors.lastname: Hennebicq
authors.forename: S
authors.initials: S
authors.lastname: Rousseaux
mesh_terms: D000328:Adult; D000782:Aneuploidy; D053627:Asthenozoospermia / Q000235:genetics / Q000503:physiopathology*; D000013:Congenital Abnormalities / Q000235:genetics; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D009845:Oligospermia / Q000235:genetics / Q000503:physiopathology*; D011237:Predictive Value of Tests; D012907:Smoking; D013076:Sperm Count; D013091:Spermatogenesis; D013094:Spermatozoa / Q000002:abnormalities*
chemical_list: D005640:Follicle Stimulating Hormone